Chemotherapy remains foundational to oncology, yet treatment response, resistance, and gastrointestinal toxicity vary widely between patients in ways that tumor stage, molecular subtype, and host pharmacogenomics do not fully explain. The gut microbiome contributes to this variability through two primary mechanisms: di...
A. Mahdy, Omneya M. Elbakry, M. Shikhoun et al.· Microorganisms· 0 citations
It is concluded that CRISPR-nanoparticle hybrids offer a transformative platform for precision antimicrobial intervention; however, no clinical trials currently exist for this specific application, and coordinated advances in nanoparticle engineering, safety characterization, and regulatory science are essential for cl...
A. Mahdy, Omneya M. Elbakry, Omar Eladl et al.· Nanotechnology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.